On-X Life Technologies, Inc.
Clinical trials sponsored by On-X Life Technologies, Inc., explained in plain language.
Now part of
Artivion, Inc.
AORT
NYSE
Makes mechanical heart valves and cardiac surgical products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a lower warfarin dose make aortic valve replacement safer? Results expected Apr 2027 (estimated)